000 01423 a2200385 4500
005 20250515132813.0
264 0 _c20090113
008 200901s 0 0 eng d
022 _a1476-5586
024 7 _a10.1593/neo.08474
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeichert, Wilko
245 0 0 _aExpression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas.
_h[electronic resource]
260 _bNeoplasia (New York, N.Y.)
_cSep 2008
300 _a1021-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCarcinoma, Endometrioid
_xmetabolism
650 0 4 _aEndometrial Neoplasms
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHistone Deacetylases
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aOvarian Neoplasms
_xmetabolism
650 0 4 _aPredictive Value of Tests
700 1 _aDenkert, Carsten
700 1 _aNoske, Aurelia
700 1 _aDarb-Esfahani, Silvia
700 1 _aDietel, Manfred
700 1 _aKalloger, Steve E
700 1 _aHuntsman, David G
700 1 _aKöbel, Martin
773 0 _tNeoplasia (New York, N.Y.)
_gvol. 10
_gno. 9
_gp. 1021-7
856 4 0 _uhttps://doi.org/10.1593/neo.08474
_zAvailable from publisher's website
999 _c18186653
_d18186653